The entire intervention is composed by four 30 minutes sessions along 1 week. Its focus is on the promotion of well-being by the use of two virtual environments ("Emotional Parks" and "Walk through Nature"). These environments allow participants to involve in different exercises (working with self statements, videos, images, slow breathing, focus on the present exercises) with the purpose of increase positive emotional states.

Participants receive the medical treatment deliver by the hospital. They fulfill several questionnaires at two moments (pre and post 1 week after). After this, they have the possibility to receive the psychological intervention.

Participants receive two sessions oriented to joy and two focused on relax. In the first 2 sessions patients can choose the environment ("Emotional Parks" or "Walk through Nature") and in the following ones participants visit the alternate environments.

Virtual Reality Intervention

The aim of this study is to analyze the effect of a brief psychological intervention supported by Information and Communication Technologies, on the subjective well-being of hospitalized cancer patients. Participants are randomly assigned to one of 2 conditions: Intervention condition (4 Virtual reality sessions) and Control condition (waiting list control group).

Promotion of Emotional Well-being in Hospitalized Cancer Patients by Virtual Reality

A Brief Psychological Intervention Using Virtual Reality for the Promotion of Emotional Well-being in Hospitalized Cancer Patients

This instrument has 9 items aimed to evaluate the cognitive and emotional representation of the illness (consequences, timeline, personal control, treatment control, identity, concern, emotional response, illness coherence and causes).

Patient has 6 alternatives of illness meaning (Loss, threat, challenge, blame-others, blame-self and opportunity). In addition to these alternatives, participant can add any other personal meaning.

7-point scale (no satisfaction - completely satisfied)

Subjective mood change after each intervention session.

Assessment of general mood, joy, sadness, anxiety, relax and vigor (7-point Likert scale)

Presence of pain, fatigue and physical discomfort (11-point Likert scale)

Level of pleasantness and perceived usefulness of each session (11-point Likert scale)

Assesses satisfaction, recommendation, utility and discomfort (11-point Likert scale)

Hospital Clínica Benidorm

Universitat Jaume I

Universitat Politècnica de València

University of Valencia

Full Professor

Symptoms and General Pathology

All Conditions

Death

The Italian version of the Liverpool Care Pathways version 11 for hospital) Programme.

No specific interventions are planned in the control wards.

The LCP-I Program is a continuous quality Improvement Program of end-of-life care implemented by a Palliative Care Unit (PCU) in a hospital Medical Ward.

The LCP-I Program

Massimo Costantini, MD

The purpose of this study is to evaluate the effectiveness of the LCP-I Program in improving the quality of end-of-life care provided to cancer patients who die on hospital medical wards as compared to standard healthcare practices.

The availability of an effective quality improvement program for the care of dying patients in hospitals is particularly relevant to the healthcare scenario. The LCP-I Program has provided enough evidence to justify a randomized trial to evaluate its effectiveness.

Although the core objective of the LCP-I is improving the quality of end of life care for dying patients, the Program targets the healthcare professionals working on the hospital ward. The only feasible method of assessing the effectiveness of this Program is by performing a cluster trial, where hospital wards are randomized to receive (or not to receive) the implementation of the LCP-I Program.

Pairs of eligible medical wards from different hospitals will be randomized to receive the experimental intervention (the LCP-I Program) or no intervention at all for the duration of the study.

The LCP-I Program will be implemented in the experimental ward by the PCU. The LCP-I Program has a duration of 6 months from the beginning of the intensive training. No intervention will be implemented in the control ward until the end of the evaluation.

Quality of end-of-life care will be evaluated for each pair of randomized wards for all eligible cancer deaths occurring in the six months after the conclusion of the LCP-I Program in the experimental ward.

The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital.

The Effectiveness of the Liverpool Care Pathway in Improving End of Life Care for Dying Cancer Patients in Hospital. A Cluster Randomised Trial.

Measured through the Global Scale of the Italian version of the Toolkit "After-death Bereaved Family Member Interview" (Teno J, et al 2001).

Measured through the specific Scales of the Italian version of the Toolkit "After-death Bereaved Family Member Interview" (Teno J, et al 2001).

Symptom scales (pain, breathlessness and vomiting) from the Italian version of VOICES (Costantini M, 2005)

Tool for recording all diagnostic and therapeutic procedures effectively performed during the last 3 days of life

Regional Palliative Care Network

Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Carcinoma, Bronchogenic

Bronchial Neoplasms

Antineoplastic Agents

All Drugs and Chemicals

Gemcitabine

Vinorelbine

Pemetrexed

Taxane

Patients with pemetrexed + platinum doublet, with or without additional targeted agents

Patients with gemcitabine + platinum doublet, with or without additional targeted agents

Patients with taxanes + platinum doublet, with or without additional targeted agents

Patients with vinorelbine + platinum doublet, with or without additional targeted agents

Patients with other platinum-based doublet, with or without additional targeted agents

Dosage, dosage form, frequency and duration according to daily hospital practice

Any platinum-based doublet chemotherapy

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)

This observational study was planned, with the primary objective to observe patient survival following first-line treatment of patients of Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) with different platinum-based doublets under routine disease management conditions. Further secondary objectives of this study are to provide insights to what extent histologic subtyping and the use of additional prognostic or predictive biomarkers are currently considered for differential therapeutic decisions under routine conditions. All of these data are critical to evaluate the factors for differential therapeutic decisions and their effect on patient outcomes in a real life setting, and they can only be obtained through observational research.

Chemotherapy in Treating Patients With Lung Cancer

First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study on Overall Survival

Eli Lilly and Company

Psychological intervention composed by four sessions along 1 week. Participants can interact with virtual environments and a multimedia system for reminiscence purposes.

Participants receive the medical treatment deliver by the hospital. After one week, they have the possibility to receive the psychological intervention.

First and third sessions are dedicated to remember positive and meaningful personal experiences. Second and fourth sessions are oriented to positive emotions by the use of VR. Participants can choose the virtual environment to work with.

Virtual Reality (VR) and Reminiscence Intervention

The aim of this study is to test the efficacy of a brief psychological intervention composed by two therapeutic modules (virtual environments and reminiscence techniques) for the promotion of wellbeing of hospitalized adult cancer patients. Participants are randomly assigned to 2 conditions: intervention condition and control condition.

Promotion of Emotional Well-being in Hospitalized Cancer Patients by Information and Communication Technologies (ICTs)

Evaluation of a Brief Psychological Intervention That Uses ICTs to Improve Well-being in Hospitalized Cancer Patients

Subjective mood change after each session.

positive affect, negative affect, well-being and calmness (5-point Likert scale)

fatigue, pain and nausea-vomiting (5-point Likert scale)

pleasantness and perceived usefulness (5-point Likert scale)

satisfaction, recommendation, utility and discomfort (5-point Likert scale)

Participants has to indicate the session duration (in minutes). An objective measure of the time lapse is also registered by the researcher.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Promotion of Emotional Well-being in Hospitalized Cancer Patients by Virtual Reality	NCT03103711	Cancer	Virtual Reality...	18 Years -	University of Valencia
The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital.	NCT01081899	Cancer	The LCP-I Progr...	18 Years -	Regional Palliative Care Network
The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital.	NCT01081899	Cancer	The LCP-I Progr...	18 Years -	Regional Palliative Care Network
Promotion of Emotional Well-being in Hospitalized Cancer Patients by Virtual Reality	NCT03103711	Cancer	Virtual Reality...	18 Years -	University of Valencia
Chemotherapy in Treating Patients With Lung Cancer	NCT01067794	Non Small Cell ...	Any platinum-ba...	18 Years -	Eli Lilly and Company
Promotion of Emotional Well-being in Hospitalized Cancer Patients by Information and Communication Technologies (ICTs)	NCT03103737	Cancer	Virtual Reality...	18 Years -	University of Valencia

Spots Global Cancer Trial Database for hospital

Every month we try and update this database with for hospital cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for hospital

Every month we try and update this database with for hospital cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for hospital cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.